-
Something wrong with this record ?
ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma
N. Concin, CL. Creutzberg, I. Vergote, D. Cibula, MR. Mirza, S. Marnitz, JA. Ledermann, T. Bosse, C. Chargari, A. Fagotti, C. Fotopoulou, A. González-Martín, SF. Lax, D. Lorusso, C. Marth, P. Morice, RA. Nout, DE. O'Donnell, D. Querleu, MR....
Language English Country Germany
Document type Consensus Development Conference, Journal Article, Practice Guideline, Systematic Review
NLK
ProQuest Central
from 2003-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2011-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 2003-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2003-01-01 to 1 year ago
- MeSH
- Biopsy standards MeSH
- Molecular Diagnostic Techniques standards MeSH
- Risk Assessment MeSH
- Carcinoma genetics pathology therapy MeSH
- Medical Oncology standards MeSH
- Humans MeSH
- Evidence-Based Medicine standards MeSH
- Biomarkers, Tumor genetics MeSH
- Endometrial Neoplasms genetics pathology therapy MeSH
- Predictive Value of Tests MeSH
- Risk Factors MeSH
- Neoplasm Staging standards MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Consensus Development Conference MeSH
- Practice Guideline MeSH
- Systematic Review MeSH
A European consensus conference on endometrial carcinoma was held in 2014 to produce multidisciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide. ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of endometrial carcinoma (27 experts across Europe). To ensure that the guidelines are evidence-based, the literature published since 2014, identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 191 independent international practitioners in cancer care delivery and patient representatives. The guidelines comprehensively cover endometrial carcinoma staging, definition of prognostic risk groups integrating molecular markers, pre- and intra-operative work-up, fertility preservation, management for early, advanced, metastatic, and recurrent disease and palliative treatment. Principles of radiotherapy and pathological evaluation are also defined.
Clinical research Unit Institut Bergonie Bordeaux France
Department of Gynaecologic Oncology Imperial College London Faculty of Medicine London UK
Department of Gynaecology Royal Marsden Hospital London UK
Department of Gynecology and Obstetrics Innsbruck Medical University Innsbruck Austria
Department of Medical Oncology Clinica Universidad de Navarra Madrid Spain
Department of Medical Oncology St James Hospital Dublin Ireland
Department of Obstetrics and Gynecologic Oncology University Hospital Strasbourg France
Department of Obstetrics and Gynecology Innsbruck Medical University Innsbruck Austria
Department of Oncology Rigshospitalet Copenhagen University Hospital Copenhagen Denmark
Department of Pathology Hospital Graz 2 Graz Austria
Department of Pathology Hospital Universitari de Bellvitge University of Barcelona Idibell Spain
Department of Pathology Leids Universitair Medisch Centrum Leiden The Netherlands
Department of Radiation Oncology Institut Gustave Roussy Villejuif France
Department of Radiation Oncology Leiden University Medical Center Leiden The Netherlands
Department of Radiation Oncology Medical Faculty of the University of Cologne Cologne Germany
Department of Radiotherapy Erasmus MC Cancer Institute Rotterdam The Netherlands
Department of Surgery Institut Gustave Roussy Villejuif France
Division of Gynecologic Oncology Fondazione Policlinico Universitario A Gemelli IRCCS Roma Italy
Evangelische Kliniken Essen Mitte Essen Germany
Histopathology and Molecular Diagnostics Azienda Ospedaliero Universitaria Careggi Florence Italy
School of Medicine Johannes Kepler University Linz Linz Austria
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011560
- 003
- CZ-PrNML
- 005
- 20210507105042.0
- 007
- ta
- 008
- 210420s2021 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00428-020-03007-z $2 doi
- 035 __
- $a (PubMed)33604759
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Concin, Nicole $u Department of Gynecology and Obstetrics, Innsbruck Medical University, Innsbruck, Austria. nicole.concin@i-med.ac.at $u Evangelische Kliniken Essen-Mitte, Essen, Germany. nicole.concin@i-med.ac.at
- 245 10
- $a ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma / $c N. Concin, CL. Creutzberg, I. Vergote, D. Cibula, MR. Mirza, S. Marnitz, JA. Ledermann, T. Bosse, C. Chargari, A. Fagotti, C. Fotopoulou, A. González-Martín, SF. Lax, D. Lorusso, C. Marth, P. Morice, RA. Nout, DE. O'Donnell, D. Querleu, MR. Raspollini, J. Sehouli, AE. Sturdza, A. Taylor, AM. Westermann, P. Wimberger, N. Colombo, F. Planchamp, X. Matias-Guiu
- 520 9_
- $a A European consensus conference on endometrial carcinoma was held in 2014 to produce multidisciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide. ESGO/ESTRO/ESP nominated an international multidisciplinary development group consisting of practicing clinicians and researchers who have demonstrated leadership and expertise in the care and research of endometrial carcinoma (27 experts across Europe). To ensure that the guidelines are evidence-based, the literature published since 2014, identified from a systematic search was reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group. The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 191 independent international practitioners in cancer care delivery and patient representatives. The guidelines comprehensively cover endometrial carcinoma staging, definition of prognostic risk groups integrating molecular markers, pre- and intra-operative work-up, fertility preservation, management for early, advanced, metastatic, and recurrent disease and palliative treatment. Principles of radiotherapy and pathological evaluation are also defined.
- 650 _2
- $a nádorové biomarkery $x genetika $7 D014408
- 650 _2
- $a biopsie $x normy $7 D001706
- 650 _2
- $a karcinom $x genetika $x patologie $x terapie $7 D002277
- 650 _2
- $a nádory endometria $x genetika $x patologie $x terapie $7 D016889
- 650 _2
- $a medicína založená na důkazech $x normy $7 D019317
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lékařská onkologie $x normy $7 D008495
- 650 _2
- $a diagnostické techniky molekulární $x normy $7 D025202
- 650 _2
- $a staging nádorů $x normy $7 D009367
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a konsensus - konference $7 D016446
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 655 _2
- $a systematický přehled $7 D000078182
- 700 1_
- $a Creutzberg, Carien L $u Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands
- 700 1_
- $a Vergote, Ignace $u Department of Gynecology and Obstetrics, Gynecologic Oncology, Leuven Cancer Institute, Catholic University Leuven, Leuven, Belgium
- 700 1_
- $a Cibula, David $u Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University, General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Mirza, Mansoor Raza $u Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
- 700 1_
- $a Marnitz, Simone $u Department of Radiation Oncology, Medical Faculty of the University of Cologne, Cologne, Germany
- 700 1_
- $a Ledermann, Jonathan A $u UCL Cancer Institute, University College, London, UK
- 700 1_
- $a Bosse, Tjalling $u Department of Pathology, Leids Universitair Medisch Centrum, Leiden, The Netherlands
- 700 1_
- $a Chargari, Cyrus $u Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France
- 700 1_
- $a Fagotti, Anna $u Division of Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Roma, Italy
- 700 1_
- $a Fotopoulou, Christina $u Department of Gynaecologic Oncology, Imperial College London Faculty of Medicine, London, UK
- 700 1_
- $a González-Martín, Antonio $u Department of Medical Oncology, Clinica Universidad de Navarra, Madrid, Spain
- 700 1_
- $a Lax, Sigurd F $u Department of Pathology, Hospital Graz II, Graz, Austria $u School of Medicine, Johannes Kepler University Linz, Linz, Austria
- 700 1_
- $a Lorusso, Domenica $u Division of Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Roma, Italy
- 700 1_
- $a Marth, Christian $u Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria
- 700 1_
- $a Morice, Philippe $u Department of Surgery, Institut Gustave Roussy, Villejuif, France
- 700 1_
- $a Nout, Remi A $u Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
- 700 1_
- $a O'Donnell, Dearbhaile E $u Department of Medical Oncology, St. James Hospital, Dublin, Ireland
- 700 1_
- $a Querleu, Denis $u Division of Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli IRCCS, Roma, Italy $u Department of Obstetrics and Gynecologic Oncology, University Hospital, Strasbourg, France
- 700 1_
- $a Raspollini, Maria Rosaria $u Histopathology and Molecular Diagnostics, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
- 700 1_
- $a Sehouli, Jalid $u Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany $u Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany
- 700 1_
- $a Sturdza, Alina E $u Department of Radiation Oncology, Comprehensive Cancer Center, Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Taylor, Alexandra $u Department of Gynaecology, Royal Marsden Hospital, London, UK
- 700 1_
- $a Westermann, Anneke M $u Department of Medical Oncology, Amsterdam University Medical Centres, Amsterdam, Noord-Holland, The Netherlands
- 700 1_
- $a Wimberger, Pauline $u Department of Gynecology and Obstetrics, TU Dresden Medizinische Fakultat Carl Gustav Carus, Dresden, Germany
- 700 1_
- $a Colombo, Nicoletta $u Gynecologic Oncology Program, European Institute of Oncology, IRCCS, Milan and University of Milan-Bicocca, Milan, Italy
- 700 1_
- $a Planchamp, François $u Clinical research Unit, Institut Bergonie, Bordeaux, France
- 700 1_
- $a Matias-Guiu, Xavier $u Department of Pathology, Hospital Universitari Arnau de Vilanova, University of Lleida, CIBERONC, Irblleida, Spain $u Department of Pathology, Hospital Universitari de Bellvitge, University of Barcelona, Idibell, Spain
- 773 0_
- $w MED00004660 $t Virchows Archiv : an international journal of pathology $x 1432-2307 $g Roč. 478, č. 2 (2021), s. 153-190
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33604759 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507105040 $b ABA008
- 999 __
- $a ok $b bmc $g 1650053 $s 1131939
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 478 $c 2 $d 153-190 $e - $i 1432-2307 $m Virchows Archiv $n Virchows Arch $x MED00004660
- LZP __
- $a Pubmed-20210420
